RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
94 hedge funds and large institutions have $636M invested in Ra Pharmaceuticals, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
36% more funds holding
Funds holding: 69 → 94 (+25)
Holders
94
Holding in Top 10
5
Calls
$346K
Puts
–
Top Buyers
| 1 | +$43.3M | |
| 2 | +$20.4M | |
| 3 | +$13.8M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$11.7M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$11.7M |
Top Sellers
| 1 | -$26.3M | |
| 2 | -$4.07M | |
| 3 | -$1.37M | |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$1.03M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.03M |